Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
44.9 EUR | +0.67% | +11.41% | +72.69% |
Apr. 30 | Transcript : AlzChem Group AG, Q1 2024 Earnings Call, Apr 30, 2024 | |
Apr. 30 | AlzChem Group AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 566M 608M | Sales 2025 * | 595M 639M | Capitalization | 454M 488M |
---|---|---|---|---|---|
Net income 2024 * | 41M 44.08M | Net income 2025 * | 46M 49.45M | EV / Sales 2024 * | 0.86 x |
Net Debt 2024 * | 31.4M 33.76M | Net Debt 2025 * | 38.83M 41.75M | EV / Sales 2025 * | 0.83 x |
P/E ratio 2024 * |
10.8
x | P/E ratio 2025 * |
9.82
x | Employees | 1,607 |
Yield 2024 * |
3.07% | Yield 2025 * |
3.36% | Free-Float | 99% |
Latest transcript on AlzChem Group AG
1 day | -0.22% | ||
1 week | +10.17% | ||
Current month | +5.71% | ||
1 month | +2.30% | ||
3 months | +53.10% | ||
6 months | +74.12% | ||
Current year | +70.77% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 17-10-01 | |
Andreas Losler
DFI | Director of Finance/CFO | - | 11-12-31 |
Chief Operating Officer | 63 | 17-10-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Markus Zöllner
CHM | Chairman | 56 | 17-08-03 |
Steve Röper
BRD | Director/Board Member | 48 | 17-10-01 |
Director/Board Member | 51 | 17-08-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 44.9 | +0.67% | 2 117 |
24-06-07 | 44.6 | +1.83% | 13,308 |
24-06-06 | 43.8 | +4.78% | 6,878 |
24-06-05 | 41.8 | +3.47% | 4,417 |
24-06-04 | 40.4 | +0.25% | 12,423 |
Delayed Quote Xetra, June 10, 2024 at 03:02 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.77% | 491M | |
+4.88% | 77.85B | |
-4.69% | 45.15B | |
+4.00% | 33.45B | |
+16.72% | 19.03B | |
+15.01% | 12.15B | |
-2.39% | 10.56B | |
-21.75% | 10.17B | |
-1.35% | 9.08B | |
-4.84% | 8.2B |
- Stock Market
- Equities
- ACT Stock